Literature DB >> 7917511

An alternative view of the Th1/Th2 switch hypothesis in HIV infection.

S Romagnani1, E Maggi, G Del Prete.   

Abstract

A theory that seeks to explain what induces the relentless progression of HIV-infected subjects to AIDS has received considerable attention. This theory holds that HIV infection results in a Th1/Th2 switch. However, analysis of constitutive cytokine mRNA expression in lymphoid tissues from HIV-infected individuals did not confirm an in vivo Th1/Th2 switch. Moreover, data available at the level of in vitro-stimulated peripheral blood mononuclear cells or cloned T cells do not provide clear evidence for a definite switch to the Th2 responses in any HIV-infected subject and in any phase of HIV infection. At most, currently available data on the profile of cytokines released in response to in vitro stimulation suggest a Th1-to-Th0 shift in a proportion of memory CD4+ T cells. On the other hand, experiments of in vitro infection with HIV of already established CD4+ T cell clones indicated that Th2 and Th0 cells support HIV replication better than Th1 cells, suggesting that early destruction of Th2 cells by direct or indirect HIV-mediated cell killing may occur. Finally, in some HIV-infected individuals with low CD4+ T cell counts, a prevalence of CD8+ T cells producing type 2 cytokines was found in both peripheral blood and skin. Thus, although the induction of a general Th2 state in HIV infection is not proven, enhanced production of type 2 cytokines may occur in a proportion of HIV-infected individuals and play some role in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917511     DOI: 10.1089/aid.1994.10.iii

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  17 in total

Review 1.  Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects.

Authors:  P De Paoli
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

2.  IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy.

Authors:  E Stylianou; P Aukrust; D Kvale; F Müller; S S Frøland
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

3.  Coxsackievirus A16 infection stimulates imbalances of T cells in children.

Authors:  Qingming Luo; Wanjun Peng; L I Chen
Journal:  Exp Ther Med       Date:  2015-04-03       Impact factor: 2.447

4.  Similar levels of human immunodeficiency virus type 1 replication in human TH1 and TH2 clones.

Authors:  J A Mikovits; D D Taub; S M Turcovski-Corrales; F W Ruscetti
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Interleukin-1 receptor antagonist gene polymorphism and circulating levels of human immunodeficiency virus type 1 RNA in Brazilian women.

Authors:  S S Witkin; I M Linhares; S Gerber; M E Caetano; A C Segurado
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Characterization of T cells and cytokines in the aqueous humour (AH) in patients with Fuchs' heterochromic cyclitis (FHC) and idiopathic anterior uveitis (IAU).

Authors:  M Muhaya; V Calder; H M Towler; B Shaer; M McLauchlan; S Lightman
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  HIV-induced IL-6/IL-10 dysregulation of CD4 cells is associated with defective B cell help and autoantibody formation against CD4 cells.

Authors:  R Weimer; S Zipperle; V Daniel; R Zimmermann; K Schimpf; G Opelz
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

8.  Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes.

Authors:  M Villacres-Eriksson
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

9.  Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditions.

Authors:  Y Suzuki; Y Koyanagi; Y Tanaka; T Murakami; N Misawa; N Maeda; T Kimura; H Shida; J A Hoxie; W A O'Brien; N Yamamoto
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  High levels of type 2 cytokine-producing cells in chronic fatigue syndrome.

Authors:  A Skowera; A Cleare; D Blair; L Bevis; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.